vs

Side-by-side financial comparison of Opendoor Technologies Inc. (OPEN) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $736.0M, roughly 1.5× Opendoor Technologies Inc.). PERRIGO Co plc runs the higher net margin — -127.8% vs -148.9%, a 21.1% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -32.1%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $67.0M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -21.1%).

Opendoor Technologies Inc. is an online company that buys and sells residential real estate. Headquartered in San Francisco, it makes instant cash offers on homes through an online process, makes repairs on the properties it purchases and re-lists them for sale. It also provides mobile application-based home buying services along with financing. As of November 2021, the company operates in 44 markets in the US.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

OPEN vs PRGO — Head-to-Head

Bigger by revenue
PRGO
PRGO
1.5× larger
PRGO
$1.1B
$736.0M
OPEN
Growing faster (revenue YoY)
PRGO
PRGO
+29.6% gap
PRGO
-2.5%
-32.1%
OPEN
Higher net margin
PRGO
PRGO
21.1% more per $
PRGO
-127.8%
-148.9%
OPEN
More free cash flow
PRGO
PRGO
$81.6M more FCF
PRGO
$148.6M
$67.0M
OPEN
Faster 2-yr revenue CAGR
PRGO
PRGO
Annualised
PRGO
1.3%
-21.1%
OPEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPEN
OPEN
PRGO
PRGO
Revenue
$736.0M
$1.1B
Net Profit
$-1.1B
$-1.4B
Gross Margin
7.7%
32.6%
Operating Margin
-20.4%
-116.0%
Net Margin
-148.9%
-127.8%
Revenue YoY
-32.1%
-2.5%
Net Profit YoY
-869.9%
-3093.9%
EPS (diluted)
$-1.42
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPEN
OPEN
PRGO
PRGO
Q4 25
$736.0M
$1.1B
Q3 25
$915.0M
$1.0B
Q2 25
$1.6B
$1.1B
Q1 25
$1.2B
$1.0B
Q4 24
$1.1B
$1.1B
Q3 24
$1.4B
$1.1B
Q2 24
$1.5B
$1.1B
Q1 24
$1.2B
$1.1B
Net Profit
OPEN
OPEN
PRGO
PRGO
Q4 25
$-1.1B
$-1.4B
Q3 25
$-90.0M
$7.5M
Q2 25
$-29.0M
$-8.4M
Q1 25
$-85.0M
$-6.4M
Q4 24
$-113.0M
$-44.4M
Q3 24
$-78.0M
$-21.0M
Q2 24
$-92.0M
$-108.4M
Q1 24
$-109.0M
$2.0M
Gross Margin
OPEN
OPEN
PRGO
PRGO
Q4 25
7.7%
32.6%
Q3 25
7.2%
36.1%
Q2 25
8.2%
34.4%
Q1 25
8.6%
37.6%
Q4 24
7.8%
33.9%
Q3 24
7.6%
37.2%
Q2 24
8.5%
37.0%
Q1 24
9.7%
33.1%
Operating Margin
OPEN
OPEN
PRGO
PRGO
Q4 25
-20.4%
-116.0%
Q3 25
-7.4%
7.0%
Q2 25
-0.8%
4.3%
Q1 25
-4.9%
4.5%
Q4 24
-8.7%
10.0%
Q3 24
-4.9%
7.4%
Q2 24
-4.8%
-2.5%
Q1 24
-7.4%
-5.1%
Net Margin
OPEN
OPEN
PRGO
PRGO
Q4 25
-148.9%
-127.8%
Q3 25
-9.8%
0.7%
Q2 25
-1.9%
-0.8%
Q1 25
-7.4%
-0.6%
Q4 24
-10.4%
-3.9%
Q3 24
-5.7%
-1.9%
Q2 24
-6.1%
-10.2%
Q1 24
-9.2%
0.2%
EPS (diluted)
OPEN
OPEN
PRGO
PRGO
Q4 25
$-1.42
$-10.23
Q3 25
$-0.12
$0.05
Q2 25
$-0.04
$-0.06
Q1 25
$-0.12
$-0.05
Q4 24
$-0.16
$-0.32
Q3 24
$-0.11
$-0.15
Q2 24
$-0.13
$-0.79
Q1 24
$-0.16
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPEN
OPEN
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$962.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.0B
$2.9B
Total Assets
$2.4B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPEN
OPEN
PRGO
PRGO
Q4 25
$962.0M
Q3 25
$962.0M
$432.1M
Q2 25
$789.0M
$454.2M
Q1 25
$559.0M
$409.9M
Q4 24
$679.0M
$558.8M
Q3 24
$837.0M
$1.5B
Q2 24
$809.0M
$542.8M
Q1 24
$990.0M
$658.5M
Stockholders' Equity
OPEN
OPEN
PRGO
PRGO
Q4 25
$1.0B
$2.9B
Q3 25
$811.0M
$4.4B
Q2 25
$631.0M
$4.5B
Q1 25
$645.0M
$4.4B
Q4 24
$713.0M
$4.3B
Q3 24
$801.0M
$4.6B
Q2 24
$845.0M
$4.5B
Q1 24
$899.0M
$4.7B
Total Assets
OPEN
OPEN
PRGO
PRGO
Q4 25
$2.4B
$8.5B
Q3 25
$2.7B
$10.1B
Q2 25
$2.9B
$10.1B
Q1 25
$3.3B
$9.8B
Q4 24
$3.1B
$9.6B
Q3 24
$3.4B
$11.2B
Q2 24
$3.4B
$10.4B
Q1 24
$3.4B
$10.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPEN
OPEN
PRGO
PRGO
Operating Cash FlowLast quarter
$70.0M
$175.4M
Free Cash FlowOCF − Capex
$67.0M
$148.6M
FCF MarginFCF / Revenue
9.1%
13.4%
Capex IntensityCapex / Revenue
0.4%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.0B
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPEN
OPEN
PRGO
PRGO
Q4 25
$70.0M
$175.4M
Q3 25
$435.0M
$51.7M
Q2 25
$823.0M
$75.9M
Q1 25
$-279.0M
$-64.5M
Q4 24
$-80.0M
$312.6M
Q3 24
$62.0M
$42.2M
Q2 24
$-399.0M
$9.5M
Q1 24
$-178.0M
$-1.4M
Free Cash Flow
OPEN
OPEN
PRGO
PRGO
Q4 25
$67.0M
$148.6M
Q3 25
$432.0M
$29.8M
Q2 25
$821.0M
$56.7M
Q1 25
$-283.0M
$-90.0M
Q4 24
$-83.0M
$274.9M
Q3 24
$56.0M
$15.1M
Q2 24
$-407.0M
$-18.9M
Q1 24
$-186.0M
$-26.5M
FCF Margin
OPEN
OPEN
PRGO
PRGO
Q4 25
9.1%
13.4%
Q3 25
47.2%
2.9%
Q2 25
52.4%
5.4%
Q1 25
-24.5%
-8.6%
Q4 24
-7.7%
24.2%
Q3 24
4.1%
1.4%
Q2 24
-26.9%
-1.8%
Q1 24
-15.7%
-2.4%
Capex Intensity
OPEN
OPEN
PRGO
PRGO
Q4 25
0.4%
2.4%
Q3 25
0.3%
2.1%
Q2 25
0.1%
1.8%
Q1 25
0.3%
2.4%
Q4 24
0.3%
3.3%
Q3 24
0.4%
2.5%
Q2 24
0.5%
2.7%
Q1 24
0.7%
2.3%
Cash Conversion
OPEN
OPEN
PRGO
PRGO
Q4 25
Q3 25
6.89×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPEN
OPEN

Segment breakdown not available.

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons